{"companyId":277656,"requestedLanguage":"en","resolvedLanguage":"en","availableLanguages":["en","ja"],"companyName":"Barinthus Biotherapeutics plc","headOfficeLocation":"Harwell, United Kingdom","presidentName":"Bill Enright","companySummary":null,"stockCode":"BRNS","currency":"USD","capital":null,"sales":null,"employees":null,"employeesConsolidated":null,"humanCheck":false,"domains":["barinthusbio.com"],"businessContents":["Clinical-stage biopharmaceutical immunotherapy development","Infectious disease, cancer, and autoimmune disease treatments"],"relations":[],"dataSources":[{"detailNumber":1,"url":"https://www.barinthusbio.com/about/","scoreAbout":500,"scoreBusiness":300,"scoreGroup":0,"scoreCustomer":0}]}